Atlas Trials

An Evaluation of LY007 Cell Injection for r/r B-NHL

Clinical trial NCT06364852 · UNKNOWN

Trial details

NCT number
NCT06364852
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
B-NHL
Start date
2021-12-25
Primary completion
2024-08-31
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.